Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer
about
LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell linesDistinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancersTransglutaminase is a tumor cell and cancer stem cell survival factorKrüppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cellsOvarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolismCD133+CD24lo defines a 5-Fluorouracil-resistant colon cancer stem cell-like phenotypeIn situ protein expression in tumour spheres: development of an immunostaining protocol for confocal microscopyDNA methyltransferases: a novel target for prevention and therapy.KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling.IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1LMore than markers: biological significance of cancer stem cell-defining molecules.ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancerA mechanically-induced colon cancer cell population shows increased metastatic potential.Colorectal adenoma stem-like cell populations: associations with adenoma characteristics and metachronous colorectal neoplasia.Cancer stem cells: a novel paradigm for cancer prevention and treatment.Endothelium originated from colorectal cancer stem cells constitute cancer blood vesselsSchlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cellsAldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cellsAldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissuesCD133-positive cancer stem cells from Colo205 human colon adenocarcinoma cell line show resistance to chemotherapy and display a specific metabolomic profile.Mantle cell lymphoma activation enhances bortezomib sensitivity.Characterization of aldehyde dehydrogenase isozymes in ovarian cancer tissues and sphere culturesTargeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1Tackling the cancer stem cells - what challenges do they pose?Cancer stem cells and epithelial ovarian cancerCalcein-effluxing human colon cancer cells are enriched for self-renewal capacity and depend on β-catenin.Transcriptional profiling of adult neural stem-like cells from the human brain.A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growthSeeing is believing: are cancer stem cells the Loch Ness monster of tumor biology?Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survivalPrognostic value of cancer stem cell marker aldehyde dehydrogenase in ovarian cancer: a meta-analysisAcetaldehyde and retinaldehyde-metabolizing enzymes in colon and pancreatic cancersCoexpression of EpCAM, CD44 variant isoforms and claudin-7 in anaplastic thyroid carcinomaExpression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.A new strategy using ALDHhigh-CD8+T cells to inhibit tumorigenesis.Resistance to dual blockade of the kinases PI3K and mTOR in KRAS-mutant colorectal cancer models results in combined sensitivity to inhibition of the receptor tyrosine kinase EGFR.Drug-eluting microarrays to identify effective chemotherapeutic combinations targeting patient-derived cancer stem cellsContribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progressionTransglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival.
P2860
Q21560941-CEC6A70F-0980-4C50-A4D4-6DE8F36C017FQ21562662-489599E6-6FA9-401A-B742-60423600D9F1Q26799862-9F0C8963-9225-4FAA-90C3-8EA0E51C225CQ28486138-317B5475-1628-47A6-BF6F-304E4BE2E565Q28538384-53BBC489-FDAB-42E4-9325-22A1FF86A1ABQ30353497-743556D6-0F63-4801-8BE1-5B16A7FC8ECAQ30493990-7EAAE7C0-5BF8-431B-ABDF-9FF0DC18CA98Q33579896-D30FEC1B-FBA0-4784-8454-7B876B6CFEB7Q33629500-52CFE376-452E-4181-ACF1-FE218FF52590Q33655332-A75DF12D-59B6-4F7D-B575-621A756E71A5Q33661278-30C2A32B-0B30-48A6-9A06-F202176751FAQ33662919-A4E15A22-DA12-4D13-AB4D-6F912D6D2A87Q33812176-FF2CFCA1-22C6-4ADC-8112-C167110CD0EFQ33836972-C2E61315-E74A-4742-86D1-8D845D86BDC8Q33867131-03ECAE25-6B12-423F-925B-8FE75B9C9847Q33873312-76B2FBAA-2E19-465E-AE34-62693F3D8505Q33906564-E875FB41-3AF7-4397-8DE9-EE7D5B314CC5Q34026132-9A2C369F-0303-4B56-B11A-9C3C6F01D915Q34076679-DB79D168-7889-4BA8-8EF0-E012388B4241Q34170564-1B0932CE-868E-4AB6-AAD8-0C4C0A5637F7Q34360347-5A4CA163-E267-426B-8F7B-EB1215377FD3Q34361095-1676D001-1119-4ACA-B4C7-2FC4DC624E98Q34420393-905F6B34-972F-4DD4-9F3B-D25FC3D2BAB3Q34486691-30E3F6EE-2A1F-4354-B7BA-0792041CC84FQ34523263-187D7900-4318-4DA6-A242-7D4E35BF069BQ34557441-6BA0793E-3DB5-4357-BC49-A98E876E3B92Q34610971-8D8E7F2F-F65A-4A85-B794-30F3DEA8E308Q34712867-468A0477-EA7F-4BD8-9CD7-D66CA571BAD0Q34718277-F2E86AAA-A490-4BA2-A52E-F9C43B2DFA0FQ34978487-1F8F0B61-DFE7-4D1D-9F8C-86F06A73F63EQ35022205-BBD5C36D-A6DC-46F2-A7DE-DB35B308F7A2Q35055205-CFBFF527-A480-4191-9607-01E7663D9537Q35140669-67B0C43D-EBF9-44B0-8AFD-0A954824C0A0Q35146510-8D57CE4F-969C-4657-9507-D586546D32D0Q35190005-F50A0F01-4F49-433D-B514-471CF5D3EC46Q35221936-047BD474-0E26-480D-A82E-F036C1A4E94CQ35412202-6DC5761B-FC87-4259-A8F7-DD457B116856Q35678181-E11DFB9E-A177-4041-8AC4-9B1DF5D5B9ADQ35754181-ED7D29F3-97D5-435B-BFCA-DE31B10ADD1EQ35858675-5C9B0024-DDC8-465F-A67A-CEEDFCEFBDA4
P2860
Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@ast
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@en
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@nl
type
label
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@ast
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@en
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@nl
prefLabel
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@ast
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@en
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@nl
P2093
P2860
P3181
P1433
P1476
Aldehyde dehydrogenase-express ...... nsition from colitis to cancer
@en
P2093
Dennis A Steindler
Edward W Scott
Henry D Appelman
Joseph E Carpentino
Mark J Hynes
Tong Zheng
P2860
P304
P3181
P356
10.1158/0008-5472.CAN-09-1132
P407
P577
2009-10-15T00:00:00Z